For research use only. Not for human consumption. · Nationwide shipping · 18+

Lyra Vital

Semax: ACTH(4-10) Analogue and the Cerebral Ischaemia Literature

Last updated 2026-09-13

Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, derived from ACTH residues 4-10 with a C-terminal Pro-Gly-Pro extension. Around two hundred and eleven results are indexed. Its literature is notably coherent: a large share uses one model, rat focal cerebral ischaemia, with gene expression as the readout.

Design and the missing hormonal activity

ACTH(4-10) is the fragment of adrenocorticotropic hormone associated with reported effects on attention and memory, distinct from the steroidogenic activity of the full hormone, which requires regions not present in the fragment.

The Pro-Gly-Pro extension, shared with Selank, slows enzymatic degradation. Notably, the Pro-Gly-Pro fragment itself appears to have activity: Medvedeva et al. (J Mol Neurosci, 2013) studied Semax and its C-terminal Pro-Gly-Pro fragment in parallel on VEGF family gene expression, which means the extension is not a pharmacologically inert stabiliser and complicates attributing effects to the full sequence.

The ischaemia gene expression literature

Dmitrieva et al. (Cell Mol Neurobiol, 2010) report that Semax and Pro-Gly-Pro activate transcription of neurotrophins and their receptor genes after cerebral ischaemia. BDNF and its receptor TrkB are the most frequently reported targets.

Medvedeva et al. (BMC Genomics, 2014) performed genome-wide transcriptional analysis in rat brain focal ischaemia, reporting effects on immune and vascular system genes. Genome-wide designs are more informative than targeted assays because they show the breadth of transcriptional change rather than only the genes chosen in advance.

Stavchansky et al. (Genes, 2022) and Filippenkov et al. (Biomedicines, 2024) continue this line, the latter on ACTH-like peptides compensating a disrupted gene expression profile a day after experimental stroke.

Outside the ischaemia model

Liu et al. (Br J Pharmacol, 2025) report that Semax targets the mu opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice. This is the most mechanistically specific recent result and comes from outside the traditional provenance, which makes it worth particular attention.

Magrì et al. (J Inorg Biochem, 2016) examine how N-terminal acetylation influences copper and zinc coordination and biological properties. Metal coordination is an underexplored dimension of this peptide given the histidine residue in its sequence.

Spirin et al. (2024) review the compound's place in therapy and rehabilitation of ischaemic stroke patients, reflecting its clinical use in some jurisdictions, though this review is published in Russian.

Evidence assessment

Evidence base: coherent and moderately sized, concentrated in one model system with gene expression as the dominant readout. Functional and clinical endpoints are less represented. The Pro-Gly-Pro fragment has activity of its own, which complicates attribution.

Published literature

211 papers indexed on PubMed for Semax. Showing 12, reviews first.

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05
  6. 06
  7. 07
  8. 08
  9. 09
  10. 10
  11. 11
  12. 12

Indexed from PubMed on 2026-07-19. Citations link to the source; we do not reproduce abstracts.

All products sold on this website are intended for research and identification purposes only. These products are not intended for human dosing, injection, or ingestion.